Jane Street

Jane Street’s Profound Medical PROF Stock Holding History

Jane Street’s Portfolio PROF Stock Details PROF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-42,000	Closed	-$272K	–	12797
2026 Q1	$272K	Buy	+42,000	New	+$290K	﹤0.01%	9439

Other funds holding PROF

Fidelity International

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Timelo Investment Management Aurora, Ontario, Canada $349M AUM 28.06% 1-Year Est. Return

Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

Z3 Capital Partners Richmond, Virginia $476M AUM

Letko, Brosseau & Associates Montreal, Quebec, Canada $6.77B AUM 38.11% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Jane Street's PROF Position: Q2 2026 in Review

Jane Street sold out of Profound Medical (PROF) in Q2 2026, closing a stake of 36,687 shares — an estimated $238K sold.

Jane Street first reported a position in PROF in Q1 2022 and held it in 3 quarters. The position peaked at $238K in Q1 2026. 56 funds tracked by Wall St. Rank hold PROF as of Q2 2026.

Jane Street reported no remaining Profound Medical position as of Q2 2026 after selling out during the quarter.
Jane Street sold 36,687 Profound Medical shares in Q2 2026, an estimated $238K.
Jane Street first reported a position in Profound Medical in Q1 2022 and held it in 3 quarters.
Jane Street's Profound Medical position peaked at $238K in Q1 2026.
56 funds tracked by Wall St. Rank held Profound Medical as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.